Nanoscope Therapeutics Inc.
PrivateLast Round
Grant
Sep 14, 2021
Total Funding Raised
$14.83M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Nanoscope Therapeutics Inc. is a biotechnology company developing gene-agnostic, vision-restoring optogenetic therapies for patients blinded by retinal degenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nanoscope Therapeutics Inc. Comparables
Compare Nanoscope Therapeutics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ray Therapeutics | 86% | |
| SparingVision | 85% | |
| Gensight Biologics | 84% | |
Nanoscope Therapeutics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 14, 2021 | ||||
| Series A | Jul 21, 2020 | ||||
| Grant | Jun 22, 2020 |
Nanoscope Therapeutics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| AG Collective Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 23, 2026
Attending ARVO 2026 Annual Meeting and Eyecelerator @ ARVO 2026.
- Mar 23, 2026
Developing MCO-010, a one-time optogenetic therapy for retinal diseases.
Nanoscope Therapeutics Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nanoscope Therapeutics Inc.'s valuation, stock price, and market status.